Galapagos' Latest Advance: Its Licensing Deal with Janssen |
Abstract
pdf
|
Business Review Editor |
|
Pfizer Acquires Immunology Company Coley |
Abstract
pdf
|
Business Review Editor |
|
Alzheimer's - A Great Deal Still to be Done |
Abstract
pdf
|
Business Review Editor |
|
Therapy Focus: Alzheimer's Disease |
Abstract
pdf
|
Business Review Editor |
|
GlaxoSmithKline Gains Antibody for Type I Diabetes |
Abstract
pdf
|
Business Review Editor |
|
Dynavax Licenses HBV Vaccine to Merck & Co. |
Abstract
pdf
|
Business Review Editor |
|
Shire Licenses Genetic Disease Therapy to Amicus |
Abstract
pdf
|
Business Review Editor |
|
Big Pharma and the Young CEO |
Abstract
html
|
Fintan Walton |
|
AVANT and Celldex in Reverse Merger |
Abstract
pdf
|
Business Review Editor |
|
Celgene Gets Pharmion for US$2.9 B |
Abstract
pdf
|
Business Review Editor |
|